Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

RISING
FDA Approves Unknown Drug — RISING

Rising Enterprises' FDA approval for the generic pharmaceutical product identified by ANDA200824 on October 18, 2011, is expected to introduce substan...

Unichem
FDA Approves LAMOTRIGINE — Unichem Pharmaceuticals (USA), Inc.

Unichem Pharmaceuticals (USA), Inc. announced the FDA approval of its oral LAMOTRIGINE generic formulation, a milestone that positions the company to ...

QUALLENT
FDA Approves GABAPENTIN — QUALLENT PHARMACEUTICALS HEALTH LLC

Quallients Pharmaceutical Health LLC received FDA approval on October 6, 2011, for the oral Gabapentin application ANDA200651, reflecting continued ma...

Sagent
FDA Approves CLINDAMYCIN — Sagent Pharmaceuticals

Sagent Pharmaceuticals has received FDA approval for the generic intramuscular injection of clindamycin phosphate, expanding its portfolio of branded ...

SAGENT
FDA Approves Unknown Drug — SAGENT PHARMS INC

On September 30, 2011, Sagent Pharmaceuticals received FDA approval for ANDA090109, a move that underpins the company’s strategy to expand its product...

HIKMA
FDA Approves Unknown Drug — HIKMA

HIKMA announced the approval of an ANDA by the FDA on September 23, 2011, which is expected to bolster the company's generic portfolio and provide inc...

Lupin
FDA Approves TRAMADOL HYDROCHLORIDE — Lupin Pharmaceuticals, Inc.

Lupin Pharmaceuticals has been granted approval by the FDA for the 50 mg oral tablets of TRAMADOL HYDROCHLORIDE, positioning the company to expand its...

Genentech,
FDA Approves ZELBORAF — Genentech, Inc.

Genentech, Inc. secured FDA approval today for ZELBORAF (vemurafenib), a targeted treatment for BRAF V600E mutation-positive melanoma, which is expect...

Lupin
FDA Approves MEFENAMIC ACID — Lupin Pharmaceuticals, Inc.

NEW YORK (Thomson Financial) - Lupin Pharmaceuticals Inc. announced Thursday that the FDA has approved its generic version of mefenamic acid tablets, ...

SpecGx
FDA Approves MORPHINE SULFATE — SpecGx LLC

# FDA Approves SpecGx LLC's Generic Morphine Sulfate Oral Formulation SpecGx LLC has received FDA approval for its generic morphine sulfate oral form...

Janssen
FDA Approves XARELTO — Janssen Pharmaceuticals, Inc.

# FDA Approves Janssen Pharmaceuticals' XARELTO (Rivaroxaban) Oral Anticoagulant Janssen Pharmaceuticals, Inc. received FDA approval for XARELTO (riv...

HIKMA
FDA Approves Unknown Drug — HIKMA

HIKMA has received FDA approval for **[substance name]**, marking a potential addition to the company’s generic portfolio and likely providing near-te...

Fresenius
FDA Approves LEVOTHYROXINE SODIUM — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC announced the FDA approval of intravenous levothyroxine sodium, potentially resolving therapeutic gaps by offering a pre-fille...

Zyla
FDA Approves OXAYDO — Zyla Life Sciences US LLC

Zyla Life Sciences US LLC has received FDA approval for OXAYDO (oxycodone hydrochloride) oral tablets, a novel formulation noted for its extended-rele...

Rising
FDA Approves RAMIPRIL — Rising Pharma Holdings, Inc.

Rising Pharma Holdings, Inc. received FDA approval on June 8, 2011, for its ANDA091604 application to market the generic version of RAMIPRIL, an oral ...

SANDOZ
FDA Approves Unknown Drug — SANDOZ

The FDA’s approval of a generic pharmaceutical from SANDOZ is poised to strengthen the company’s market presence and drive revenue growth, however, th...

PLANO
FDA Approves Unknown Drug — PLANO PHARMS

On May 9, 2011, Plano Pharmaceuticals secured regulatory approval for NDA022485, a milestone that marked a significant expansion of the company’s comm...

ACTAVIS
FDA Approves Unknown Drug — ACTAVIS LABS FL INC

On March 22, 2011, Actavis Labs Fl Inc received FDA approval for ANDA090084, a generic drug anticipated to drive incremental sales in the specific the...

Bayer
FDA Approves GADAVIST — Bayer HealthCare Pharmaceuticals Inc.

# FDA Approves Bayer's Gadavist (Gadobutrol) for MRI Contrast Imaging Bayer HealthCare Pharmaceuticals Inc. received FDA approval for Gadavist (gadob...

PETNET
FDA Approves FLUDEOXYGLUCOSE F 18 — PETNET Solutions, Inc.

PETNET Solutions, Inc. has received new approval for the ANDA079086 for Fludeoxyglucose F-18, a move that bolsters the company’s portfolio of PET imag...